BC

Broadfin Capital Portfolio holdings

AUM $403M
This Quarter Return
+20.83%
1 Year Return
+74.97%
3 Year Return
+245.63%
5 Year Return
+336.04%
10 Year Return
–
AUM
$1.05B
AUM Growth
+$1.05B
Cap. Flow
-$66M
Cap. Flow %
-6.27%
Top 10 Hldgs %
51.35%
Holding
73
New
4
Increased
17
Reduced
19
Closed
7

Top Buys

1
HRTX icon
Heron Therapeutics
HRTX
$27.6M
2
TVTX icon
Travere Therapeutics
TVTX
$18.1M
3
TEVA icon
Teva Pharmaceuticals
TEVA
$13.8M
4
ACOR
Acorda Therapeutics, Inc.
ACOR
$12.6M
5
ISEE
IVERIC bio, Inc. Common Stock
ISEE
$10.7M

Top Sells

1
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$51.9M
2
NVRO
NEVRO CORP.
NVRO
$35.7M
3
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$24.7M
4
CSII
Cardiovascular Systems, Inc.
CSII
$23.7M
5
ANGO icon
AngioDynamics
ANGO
$12.6M

Sector Composition

1 Healthcare 89.55%
2 Financials 0.25%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
HZNP
1
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$99.8M 8.94% 5,503,182 -1,360,666 -20% -$24.7M
TVTX icon
2
Travere Therapeutics
TVTX
$1.56B
$77.6M 6.96% 3,469,271 +806,680 +30% +$18.1M
NVDQ
3
DELISTED
Novadaq Technologies Inc.
NVDQ
$59.9M 5.37% 5,174,209 -291,007 -5% -$3.37M
PGNX
4
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$56.7M 5.08% 8,951,169 – –
AVDL
5
Avadel Pharmaceuticals
AVDL
$1.43B
$54.5M 4.88% 4,394,464 – –
ANGO icon
6
AngioDynamics
ANGO
$417M
$50.7M 4.54% 2,890,679 -716,603 -20% -$12.6M
HRTX icon
7
Heron Therapeutics
HRTX
$207M
$49.1M 4.4% 2,850,000 +1,599,896 +128% +$27.6M
LJPC
8
DELISTED
La Jolla Pharmaceutical Company
LJPC
$34.4M 3.09% 1,447,053 +165,680 +13% +$3.94M
ENDP
9
DELISTED
Endo International plc
ENDP
$29.3M 2.63% 1,454,538 +425,736 +41% +$8.58M
PETX
10
DELISTED
Aratana Therapeutics, Inc.
PETX
$28.9M 2.59% 3,085,979 -342,886 -10% -$3.21M
ATRS
11
DELISTED
Antares Pharma, Inc.
ATRS
$25M 2.24% 14,885,393 – –
IOVA icon
12
Iovance Biotherapeutics
IOVA
$807M
$21.7M 1.95% 2,638,259 -532,500 -17% -$4.38M
SCTL
13
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$21.7M 1.94% 2,450,086 +390,000 +19% +$3.45M
ARLZ
14
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
$21.4M 1.92% 4,406,990 +300,000 +7% +$1.46M
ISEE
15
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$18.9M 1.7% 410,000 +232,600 +131% +$10.7M
GNMX
16
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
$18.8M 1.68% 3,370,306 – –
TLGT
17
DELISTED
Teligent, Inc
TLGT
$16.7M 1.5% 2,201,901 -314,600 -13% -$2.39M
ADXS
18
DELISTED
Advaxis, Inc.
ADXS
$16.7M 1.5% 1,564,679 -125,838 -7% -$1.35M
RXDX
19
DELISTED
Ignyta, Inc.
RXDX
$14.2M 1.27% 2,256,546 – –
DVAX icon
20
Dynavax Technologies
DVAX
$1.19B
$14.1M 1.27% 1,347,810 +800,000 +146% +$8.39M
BDSI
21
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$14M 1.26% 5,188,794 – –
TEVA icon
22
Teva Pharmaceuticals
TEVA
$21.1B
$13.8M 1.24% +300,000 New +$13.8M
AEGR
23
DELISTED
Aegerion Pharmaceuticals, Inc.
AEGR
$13M 1.16% 4,361,291 +351,000 +9% +$1.04M
ACOR
24
DELISTED
Acorda Therapeutics, Inc.
ACOR
$12.6M 1.13% +604,700 New +$12.6M
DSCI
25
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$12M 1.07% 2,562,104 – –
1
2 3